Cipla Ltd. — Major Shareholding Notification 2022

Feb 15, 2022

15^th February, 2022

• (1) BSE Limited Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street. Mumbai 400 001
• Scrip Code: 500087
• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG (4) Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg
• (2) National Stock Exchange of India Limited Listing Department Exchange Plaza, 5^th floor, Plot no. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: CIPLA EQ
• Cipla Limited Cipla House Peninsula Business Park Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013

Sub: Disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Dear Sir/Madam,

This has reference to the captioned subject, in view of that please find enclosed the relevant disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 in connection with the change in shareholding of :

• 1. Dr. Y. K. Hamied, Promoter consequent to the sale of 1.67% stake (i.e. 1,34,46,504 equity shares) of Cipla Limited.
• 1. Mr. M. K. Hamied, Promoter consequent to the sale of 0.83% stake (i.e. 67,23,252 equity shares) of Cipla Limited.

Though the individual resultant change is within the threshold limits this disclosure is fined for grand order

You are requested to kindly take the same on record

Thanking you. Yours Faithfully,

J.K. Hamis 2.

Dr. Y. K. Hamied Apt 3301, Los Grandos, Edificio E4. Otra De Cadiz km 175. Puerto Banus. 29660- Marbella Spain Contact No: 022-24826000

ku. I. Hawined

Mr. M. K. Hamied Flat No. 1C, "Somerser Place", Bhulabhai Desai Road, Mumbai-400026 Contact No. 022-24826000

Encl: As above

Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011

Name of the Target Company (TC)	CIPLA LIMITED
Name(s) of the Aequirer/-Seller and Persons Acting in	Dr. Y. K. Hamied
Concert (PAC) with the acquirer	Mr. M. K. Hamied
	Persons acting in concert for the purpose of this disclosure: -
	Promoters (1) Dr. Y. K. Hamied
	(2) Mr. M. K. Hamied
	Member of Promoter Group (1) Farida Hamied
	(2) Sophie Ahmed
	(3) Shirin Hamied
	(4) Kamil Hamied
	(5) Samina Hamied
	(6) Rumana Hamied
	(7) MN Rajkumar Garments LLP
	(8) Shree Riddhi Chemicals LLP
	(9) Alps Remedies Private Limited
	(10) Hamsons Laboratories LLP
	(11) Neo Research Labs Private Limited
	(12) Okasa Pharma Private Limited
	PAC
	(1) Sara Ahmed
	(2) Farah Barua
	(3) Monisha Ahmed
	Note: The person/ entities listed above (except Dr. $Y_{\text{eff}}$
	K. Hamied and Mr. M. K. Hamied - Seller) have been
	so named but have not sold any shares or voting rights
	in the Target Company hereunder.
Whether the Acquirer/ Seller belongs to Promoter/Promoter
group	Yes
	Bombay Stock Exchange of India Limited
Name(s) of the Stock Exchange(s) where the shares of TC are Listed	National Stock Exchange of India Limited
	Global Depository Receipts (GDRs): Luxembourg Stock Exchange

Details of the acquisition / disposal as follows	Number	% w.r.t.total share/voting capital wherever applicable $(*)$	% w.r.t. total diluted share/voting capital of the $TC(**)$
Before the Acquisition/Safe under consideration, holding of:
a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/lien/non-	29,62,85,134	36.73%	36.73%
disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares	NIL	NIL.	NIL
d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carryingvoting rights	NIL	NIL	NIL
in the T C (specify holding in each category)	NIL	NIL.	NIL
$e)$ Total (a+b+c+d)	29,62,85,134	36.73%	36.73%
Details of acquisition/sale a) Shares carrying voting rights acquired/sold $#$	2,01,69,756	2.50%	2.50%
b) VRs acquired /sold otherwise than by shares	NIL	NIL	NIL
c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carryingvoting rights in the TC (specify holding in each category) acquired/sold	NIL	NIL	NIL
d) Shares encumbered / invoked/released by the acquirer $e)$ Total (a+b+c+/-d) # Total sale comprises of transaction by the promoters i.e Dr. Ya	NIL 2,01,69,756	NIL 2.50%	NIL 2.50%
K. Hamied sold 1,34,46,504 shares representing 1.67% of the total share capital and Mr. M. K. Hamied sold 67,23,252 shares representing 0.83% of the total share capital
After the acquisition/sale, holding of:
a) Shares carrying voting rights	27,61,15,378	34.23%	34.23%
b) Shares encumbered with the acquirer c) VRs otherwise than by shares	NIL.	NIL	NIL
d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carryingvoting rights	NIL NIL	NIL NIL	NIL NIL
in the TC (specify holding in each category) after acquisition c) Total $(a+b+c+d)$	27,61,15,378	34.23%	34.23%

$\frac{16}{16}$

Mode of acquisition / sale (e.g. open market / off-market / public) issue / rights issue / preferential allotment / inter-se transfer etc).	Open Market Sale
Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable	15 th February 2022
Equity share capital / total voting capital of the TC before the	80,67,90,214 equity shares
Equity share capital/ total voting capital of the TC after the said aequisition / sale	80,67,90,214 equity shares
Total diluted share/voting capital of the TC after the said aequisition/sale	80,67,90,214 equity shares ^
ESOPs/ESARs granted by the Company have not been considered for the purpose of calculating the diluted share capital in the above disclosure.

(*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements), Regulations

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

1. K. Hamil.

Dr. Y.K. Hamied

Au. X. Atamied

Mr. M. K. Hamied

Place: Mumbai

Date: 15th February 2022